Link to this page
Medical Subject Headings
| Preferred Name | Dasatinib | |
| Synonyms |
N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide BMS-354825 Sprycel 354825, BMS (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide BMS 354825 BMS354825 |
|
| Definitions |
A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000069439 |
|
| altLabel |
N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide BMS-354825 Sprycel 354825, BMS (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide BMS 354825 BMS354825
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C1328005 C1455147 C1723829 C2000119
|
|
| DC |
1
|
|
| definition |
A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.
|
|
| DX |
20160101
|
|
| HN |
2016 (2004)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
RBZ1571X5H 0
|
|
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2016; DASATINIB was indexed under PYRIMIDINES and THIAZOLES 2004-2015
|
|
| Mapped from | ||
| MDA |
20150701
|
|
| MMR |
20230804
|
|
| MN |
D02.886.675.184 D03.383.742.148 D03.383.129.708.198
|
|
| notation |
D000069439
|
|
| PA |
D000092004 D000970
|
|
| prefLabel |
Dasatinib
|
|
| RR |
302962-49-8 (dasatinib)
|
|
| TERMUI |
T712295 T602501 T674818 T000879951 T602502 T602500 T602503
|
|
| TH |
NLM (2004) NLM (2008) FDA SRS (2013) USAN (19XX) INN (19XX) NLM (2006)
|
|
| tui |
T109 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |